Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study (Q34617300)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study |
scientific article |
Statements
1 reference
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study (English)
1 reference
Giuseppe Colucci
1 reference
Francesco Di Costanzo
1 reference
Bruno Massidda
1 reference
Elisa Dapretto
1 reference
Luigi Manzione
1 reference
Elena Piazza
1 reference
Mirella Sannicolò
1 reference
Marco Ciaparrone
1 reference
Luigi Cavanna
1 reference
Francesco Giuliani
1 reference
Antonio Testa
1 reference
Paolo Pederzoli
1 reference
Ciro Gallo
1 reference
Francesco Perrone
1 reference
Gruppo Oncologico Italia Meridionale (GOIM)
1 reference
Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente (GISCAD)
1 reference
Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
1 reference
1 reference
Identifiers
1 reference